Press "esc" to clear
Go to Advanced Search

Showing results

110 of 65
Mitchelletal_horizontal.jpg
  • Embargo expired:
    17-May-2018 9:00 AM EDT

Article ID: 694507

Single Surface Protein Boosts Multiple Oncogenic Pathways in Acute Myeloid Leukemia, Study Reveals

The Rockefeller University Press

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia (AML) plays a much wider role in the disease than previously thought. The study, which will be published May 17 in the Journal of Experimental Medicine, raises hopes that current efforts to target this signaling protein could be a successful strategy to treat AML and other blood cancers.

Released:
14-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Schmidt1.jpg
  • Embargo expired:
    16-May-2018 9:00 AM EDT

Article ID: 694259

Cell Type Switch Helps Colon Cancer Evade Treatment, Study Suggests

The Rockefeller University Press

Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States.

Released:
9-May-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Caoetal.jpg
  • Embargo expired:
    4-May-2018 9:00 AM EDT

Article ID: 693698

Osteoporosis Drug Could Be Used to Treat Aggressive Form of Breast Cancer, Researchers Say

The Rockefeller University Press

Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, an aggressive form of the disease that is largely untreatable. But the study, which will be published May 4 in the Journal of Experimental Medicine, reveals that the widely used osteoporosis drug zoledronic acid inhibits UGT8 and prevents the spread of basal-like breast cancer in mice, suggesting that this drug could also be used to treat the disease in humans.

Released:
30-Apr-2018 9:40 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Stockstilletal.jpg
  • Embargo expired:
    27-Apr-2018 9:00 AM EDT

Article ID: 693266

Multiple Sclerosis Drug Could Reduce Painful Side Effects of Common Cancer Treatment, Researchers Suggest

The Rockefeller University Press

Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published April 27 in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing myeloma patients to successfully complete their treatment and relieving the pain of myeloma survivors.

Released:
23-Apr-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Teitz.jpg
  • Embargo expired:
    7-Mar-2018 9:00 AM EST

Article ID: 690247

Researchers Identify New Drugs That Could Help Prevent Hearing Loss

The Rockefeller University Press

Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.

Released:
28-Feb-2018 10:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Baranska1.jpg
  • Embargo expired:
    6-Mar-2018 9:00 AM EST

Article ID: 690244

How Tattoos Are Maintained by Macrophages Could Be Key to Improving Their Removal

The Rockefeller University Press

Researchers in France have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the researchers say, the cells can pass on the pigment to new cells when they die. The study, which will be published March 6 in the Journal of Experimental Medicine, suggests ways to improve the ability of laser surgery to remove unwanted tattoos.

Released:
28-Feb-2018 9:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    6-Mar-2018 9:00 AM EST

Article ID: 690436

Preventing Exhaustion in Immune Cells Boosts Immunotherapy in Mice

Health Sciences at the University of Pittsburgh

Immunotherapy does not work for a majority of cancer patients. Preventing or reversing metabolic exhaustion in cancer-killing T-cells could boost its effectiveness.

Released:
2-Mar-2018 12:40 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Hu.jpg
  • Embargo expired:
    14-Feb-2018 9:00 AM EST

Article ID: 689123

Researchers Successfully Reverse Alzheimer’s Disease in Mouse Model

The Rockefeller University Press

A team of researchers from the Cleveland Clinic Lerner Research Institute have found that gradually depleting an enzyme called BACE1 completely reverses the formation of amyloid plaques in the brains of mice with Alzheimer’s disease, thereby improving the animals’ cognitive function. The study, which will be published February 14 in the Journal of Experimental Medicine, raises hopes that drugs targeting this enzyme will be able to successfully treat Alzheimer’s disease in humans.

Released:
7-Feb-2018 8:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 688756

New Explanation for Why Airways Close in Asthma Holds Promise for Future Class of Drugs

The Rockefeller University Press

Houston Methodist researchers have a new explanation for what causes the lungs’ airways to close during asthma attacks. The researchers who published the study in the Feb. 5 issue of the Journal of Experimental Medicine note that the discovery holds promise for developing a new class of drugs different from the steroids currently used to treat asthma.

Released:
31-Jan-2018 2:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
anemia-research-team.jpg

Article ID: 688336

Anemia Discovery Offers New Targets to Treat Fatigue That Affects Millions

University of Virginia Health System

UVA has discovered an unknown biological process that controls the production of red blood cells, which carry oxygen to the body. The discovery could help doctors develop new treatments for anemia, which affects millions.

Released:
23-Jan-2018 12:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 65





Chat now!